These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24934488)

  • 1. Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception.
    Johnson LN; Sammel MD; Dillon KE; Lechtenberg L; Schanne A; Gracia CR
    Fertil Steril; 2014 Sep; 102(3):774-781.e3. PubMed ID: 24934488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
    Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
    Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.
    Bas-Lando M; Rabinowitz R; Farkash R; Algur N; Rubinstein E; Schonberger O; Eldar-Geva T
    Gynecol Endocrinol; 2017 Oct; 33(10):797-800. PubMed ID: 28454495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
    Nelson SM; Klein BM; Arce JC
    Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New automated antimüllerian hormone assays are more reliable than the manual assay in patients with reduced antral follicle count.
    Tadros T; Tarasconi B; Nassar J; Benhaim JL; Taieb J; Fanchin R
    Fertil Steril; 2016 Dec; 106(7):1800-1806. PubMed ID: 27692436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.
    Anderson RA; Anckaert E; Bosch E; Dewailly D; Dunlop CE; Fehr D; Nardo L; Smitz J; Tremellen K; Denk B; Geistanger A; Hund M
    Fertil Steril; 2015 Apr; 103(4):1074-1080.e4. PubMed ID: 25681853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan.
    Cameron K; Sammel MD; Prewitt M; Gracia C
    J Clin Endocrinol Metab; 2019 May; 104(5):1813-1822. PubMed ID: 30566616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility.
    Greenwood EA; Cedars MI; Santoro N; Eisenberg E; Kao CN; Haisenleder DJ; Diamond MP; Huddleston HG;
    Fertil Steril; 2017 Dec; 108(6):1070-1077. PubMed ID: 29202959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages.
    Grande M; Borobio V; Bennasar M; Stergiotou I; Mercadé I; Masoller N; Peñarrubia J; Borrell A
    Fertil Steril; 2015 May; 103(5):1221-7.e2. PubMed ID: 25796318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cancer therapies on ovarian reserve.
    Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
    Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian reserve markers in women using various hormonal contraceptives.
    Landersoe SK; Forman JL; Birch Petersen K; Larsen EC; Nøhr B; Hvidman HW; Nielsen HS; Nyboe Andersen A
    Eur J Contracept Reprod Health Care; 2020 Feb; 25(1):65-71. PubMed ID: 31852271
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging.
    Bentzen JG; Forman JL; Johannsen TH; Pinborg A; Larsen EC; Andersen AN
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1602-11. PubMed ID: 23463653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tamoxifen therapy on fertility in breast cancer survivors.
    Shandley LM; Spencer JB; Fothergill A; Mertens AC; Manatunga A; Paplomata E; Howards PP
    Fertil Steril; 2017 Jan; 107(1):243-252.e5. PubMed ID: 27887709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age.
    Bentzen JG; Forman JL; Larsen EC; Pinborg A; Johannsen TH; Schmidt L; Friis-Hansen L; Nyboe Andersen A
    Hum Reprod; 2013 Jan; 28(1):247-55. PubMed ID: 23136135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.